SCHEMBL7125293

SCHEMBL7125293

CC(=O)Nc1ccc(S(=O)(=O)NC(CCc2ccccc2)C(=O)NC(C)(C)C)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.59
HPN P05981 1/20 0.59
ALDH1A1 P00352 4/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
POLB P06746 1/20 0.52
MAPT P10636 4/20 0.50
USP2 O75604 1/20 0.50
MMP9 P14780 3/20 0.49
GFER P55789 2/20 0.49
MMP2 P08253 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PSMB8 P28062 1/20 0.48
MMP1 P03956 1/20 0.47
MMP14 P50281 1/20 0.47
ADAM17 P78536 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124459 0.89 ALDH1A1 (0.57) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL7127817 0.87 MMP2 (0.53) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL7127019 0.84 PLAU (0.60) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL7121669 0.84 ALDH1A1 (0.63) PLAUHPNALDH1A1POLBMMP9
SCHEMBL7118405 0.83 MMP2 (0.50) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL7124501 0.83 PLAU (0.54) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL7117861 0.78 PSMB8 (0.54) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL7126168 0.77 MMP2 (0.49) PLAUHPNALDH1A1MEN1KMT2A
SCHEMBL5189116 0.77 MMP9 (0.76) ALDH1A1MEN1KMT2ANPSR1POLB
SCHEMBL7118677 0.77 MMP2 (0.49) PLAUHPNALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO PLAU 1115/4885HPN 247/4885ALDH1A1 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.